KFDA - NewsChannel 10 / Amarillo, TX: newschannel10.comThreshold Pharmaceuticals 3Q loss widens on costs
Member Center:
 |
 |
REDWOOD CITY, Calif. (AP) - Threshold Pharmaceuticals Inc., a development-stage biotechnology company, said late Thursday its third-quarter loss widened on higher research, development, and interest expenses.
The company lost $6.2 million, or 40 cents per share, compared with a loss of $4.6 million, or 49 cents per share, during the year-ago period.
Threshold reported no revenue, compared with $362,000 a year prior.
Operating expenses rose 4 percent to $5.2 million as the company continued developing its potential cancer treatment TH-302. Meanwhile, interest expense surged to $957,000 from $13,000.
Copyright 2009 The Associated Press. All rights reserved. This material may not be published, broadcast, rewritten or redistributed.
Click here to find daily tax tips, forms, rules, and FAQ's. Brought to you by Jackson-Hewitt.
